AGM outcome: re-appointment of secretarial auditor, director, RPT approval

Management Changes View source PDF Explain this filing

MEDIORG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹24.15

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%-3.4% vs market

On the reaction day the stock moved 3.4 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-5.0-1.6-3.4

Next day

-0.4-0.6+0.2

—-0.8—

+1.7-2.1+3.8

—-2.1—

—-0.8—

—-3.8—

15d

+5.4-6.9+12.3

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Medicamen Organics held its 31st AGM on September 25, 2026. Shareholders approved audited FY26 financial statements, re-appointed Mr. Ashutosh Gupta as director (retiring by rotation), re-appointed Ms. Divya Rani as secretarial auditor for FY27, and approved material related party transactions with subsidiary Grande Etoile Pharmaceuticals.

Likely market impact

Routine AGM items. Re-appointment of secretarial auditor is standard, not a concern. RPT approval with subsidiary warrants ongoing monitoring.